Inhibition of measles virus replication by 5'-Norcarbocyclic nucleoside analogs
International Medical Press
Despite intense efforts to increase vaccine coverage, measles virus (MV) still causes significant morbidity and mortality in the world, sometimes as the result of severe, chronic, lethal disease. In an effort to develop therapies to supplement immunization strategies, a number of 5′-nor carbocyclic adenosine analogues were evaluated for anti-MV activity in CV-1 monkey kidney cells. Of those compounds tested, those either unsubstituted at C4 or possessing a hydroxyl, azido or amino substituent at that position were the most active, with particularly significant inhibition of MV, strain Chicago-1. The EC50 values against this strain ranged from100 mg/ml in actively growing and stationary-phase cells. Results suggest that these compounds may be clinically useful anti-MV virus agents.
Barnard, D.L, Stowell, V., Seley, K.L., Hegde, V.R., Subha, R., Rajappan, P., Schneller, S.W. Smee, D.F. and Sidwell, R.W. 2001. Inhibition of measles virus replication by 5'-Nor carbocyclic nucleoside analogs. Antiviral Chem. & Chemother. 12: 221-230. PMID: 11771733
Originally published by International Medical Press. Publisher's PDF available through remote link.